Local drug firm sells tech for $25 million

Intelliject, a Richmond-based pharmaceutical company, just closed a $25 million licensing deal with drug maker Sanofi-aventis. Intelliject also secured $208 million in milestone payments that are promised as the product moves through the regulatory process and into the marketplace.

Intelliject was founded in 2004 by a local set of twins, Evan and Eric Edwards. Both suffer from anaphylaxis — severe allergic reactions to certain foods and insect bites. (The duo were on Style Weekly’s annual Top 40 under 40. You can read more about them here.)

The treatment for such reactions is a shot of epinephrine, also known as adrenaline. That drug is typically administered in the emergency room, or by a portable injection device carrying a predetermined dosage of the drug. Read more